Exploring ASIC2: A Potential Drug Target and Biomarker for Acid Sensing and Ion Channel Function

Target Name: ASIC2

NCBI ID: G40

ASIC2

Exploring ASIC2: A Potential Drug Target and Biomarker for Acid Sensing and Ion Channel Function

Abstract:

Acid sensing ion channel subunit (ASIC) 2, also known as MDEG1, is a transmembrane protein that plays a crucial role in the regulation of acid-sensing channels in the intestinal epithelial cell lineage. ASIC2 is the key component of the TRPV1 receptor, which is responsible for mediating the sensing of changes in pH levels in the intestinal lumen. The dysfunction of ASIC2 has been implicated in various diseases, including inflammatory bowel disease, neuromuscular disorders, and neuropsychiatric disorders. In this article, we review the current research on ASIC2 , its functions, and potential as a drug target or biomarker.

Introduction:

The second acid sensing ion channel (ASIC) is a transmembrane protein that is expressed in the epithelial cell lineage of the intestine. It is a key component of the TRPV1 receptor, which is responsible for mediating the sensing of changes in pH levels in the intestinal lumen. The TRPV1 receptor is a G protein-coupled receptor (GPCR), which is a family of transmembrane proteins that play a crucial role in sensory signaling. They are involved in the perception of various stimuli, including changes in temperature, light, and chemical concentrations.

ASIC2 functions as the key component of the TRPV1 receptor, allowing it to detect changes in pH levels in the intestinal lumen. When the pH level in the intestinal lumen drops, the concentration of positively charged ions, such as H+, increases, which triggers the TRPV1 receptor. This signaling cascade allows the TRPV1 receptor to transmit signals to various downstream effectors, including the production of pro-inflammatory cytokines and the activation of pain receptors.

Dysfunction of ASIC2 in disease:

The dysfunction of ASIC2 has been implicated in various diseases, including inflammatory bowel disease, neuromuscular disorders, and neuropsychiatric disorders.

In inflammatory bowel disease (IBD), ASIC2 has been shown to be involved in the regulation of pro-inflammatory cytokine production and the modulation of immune cell function. Several studies have shown that individuals with IBD have decreased levels of ASIC2 in their intestinal epithelial cells , which may contribute to the dysfunction of the TRPV1 receptor and the development of IBD.

In neuromuscular disorders, such as myasthenia gravis, ASIC2 has been shown to be involved in the regulation of muscle contractions. Studies have shown that individuals with neuromuscular disorders have decreased levels of ASIC2 in their muscle cells, which may contribute to the dysfunction of the muscle -Neural junctions and the development of neuromuscular disorders.

In neuropsychiatric disorders, such as schizophrenia and depression, ASIC2 has been shown to be involved in the regulation of neurotransmitter signaling. Studies have shown that individuals with neuropsychiatric disorders have decreased levels of ASIC2 in their brain cells, which may contribute to the dysfunction of the neurotransmitter signaling system and the development of neuropsychiatric disorders.

Potential as a drug target or biomarker:

The dysfunction of ASIC2 has led to the interest in using ASIC2 as a drug target or biomarker for various diseases.

In the context of inflammatory bowel disease (IBD), ASIC2 has been shown to be involved in the regulation of pro-inflammatory cytokine production and the modulation of immune cell function. Therefore, ASIC2 may be a potential drug target for IBD. Studies have shown that inhibitors of ASIC2 can reduce the production of pro-inflammatory cytokines and improve the function of TRPV1 receptors in I

Protein Name: Acid Sensing Ion Channel Subunit 2

Functions: Cation channel with high affinity for sodium, which is gated by extracellular protons and inhibited by the diuretic amiloride. Also permeable for Li(+) and K(+). Generates a biphasic current with a fast inactivating and a slow sustained phase. Heteromeric channel assembly seems to modulate

The "ASIC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASIC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets